On day 35 after tumor cell injection (prior to the disease-associated terminal end point), the animals were sacrificed, and analysis of the BMMs from mCh-AML–engrafted animals showed increased mCherry fluorescence compared with BMMs from control animals transplanted with nonmalignant CD34+ cells (Figure 5H). The gene discussed is CD34; the disease is neoplasm.